Category: Parry
-
Revive Therapeutics (RVV.C) warned about overhype, but up 26% on clinical trial news
Oddball pharmaceutical player Revive Therapeutics (RVV.C) found itself on the back end of a warning by the BCSC this week, that certain German players in the smallcap promotion space had over-hyped the mushroom/cannabis/biotech deal and promised big wins inappropriately for anyone who invested. As a marketing partner of Revive, I got a few panicky texts…
-
Cannabis beverages are here at last: So where the hell are they?
When the cannabis edibles space first became a potentially legal thing in Canada, my first thought was about how my life would change for the better when I could drink a beverage that would either hit me with a nice shot of CBD, or wipe me out with THC, or hey – maybe both. Fast…
-
iAnthus (IAN.C) defaults on debenture payments – but is that a weakness or a tactic?
Long time readers know, a year or two back, we wrote a lot about a US multi-state operator (MSO) in the cannabis dispensary space, iAnthus (IAN.C). We liked the company as it accelerated its dispensary acquisition program but stopped coverage in early 2019, with the shareprice in the $5 range, as it began to overpay…
-
Powerband Solutions (PBX.V) is a serious auto financing business that, admittedly, resembles a pump
I have a list of companies that want me to write about them that, for the last few years, has never got to an end. Heck, the list of companies that’ll pay me to look at them rarely gets to zero, and they take precedence over the freebies. So when I spot something in the…
-
James A. Wagner Cultivation (JWCA) goes into creditor protection, financier jumps 50%
It’s never been clearer that many Canadian cannabis companies were built, from the outset, poorly. As the economy creaks and groans and every sector takes a hit from COVID-19 effects, cannabis should be an exception to the rule because, if my circle is any indication, a lot of folks are at home, bored, and getting…
-
Revive Therapeutics (RVV.C) finds pharma asset under the couch that may treat COVID-19
When new sectors emerge, as cannabis did in 2013 and psychedelics are doing right now, microcap companies that have struggled in other sectors will often pivot into new business. Miners become weed companies, then biotech companies, then shroom companies, as boards and management pursue new opportunities that might one day prove better than the last.
-
GTEC Holdings (GTEC.C) CEO locks down the future, thumps chest on Twitter
GTEC Holdings (GTEC.C) is a company we’ve written about a lot, a BC-based cannabis grower that laid out a business model of multiple small licensed grow facilities, hitting the premium artisan weed market. Their products are great, their costs are low, and they’ve never yet benefited from the irrational weed booms of the ’15, ’16,…
-
Green Organic Dutchman (TGOD.T) drops fat quarterly loss, underwhelming revenues
No company in the Canadian cannabis space polarizes people like Green Organic Dutchman (TGOD.T), which roared to the public markets on perhaps the biggest promote yet seen, raised nine-digit totals along the way, swept in more first time private placement participants than any company before them, and then did… well… nothing, for a long time.…